Who Owns Silexion Therapeutics Stock?
NASDAQ: SLXNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.32%
- Held by insiders
- 14.67%
- Institutional holders
- 11
- Institutions 0.3%
- Insiders 14.7%
- Public and other 85.0%
Who owns Silexion Therapeutics stock?
Institutional investors own about 0.3% of Silexion Therapeutics's shares, spread across 11 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 14.67% of SLXN.
The largest institutional holders are HRT Financial LP (0.11%), UBS Group AG (0.01%) and Montag A & Associates Inc (0.00%). Together, the top 6 institutions control 0.1% of shares outstanding. In their latest filings, 6 of the top 6 institutions increased their SLXN positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SLXN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| HRT Financial LP | 15.24K | 0.11% | +100.0% |
| UBS Group AG | 1.41K | 0.01% | +100.0% |
| Montag A & Associates Inc | 300 | 0.00% | +100.0% |
| Royal Bank of Canada | 76 | 0.00% | +100.0% |
| Pflug Koory, LLC | 33 | 0.00% | +100.0% |
| SBI Securities Co., Ltd. | 2 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SLXN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 587 | 0.03% |
Frequently asked questions
Who is the largest shareholder of Silexion Therapeutics?
HRT Financial LP is the largest institutional shareholder of SLXN, owning 0.11% of shares outstanding (15.24K shares) as of its latest 13F filing.
What percentage of Silexion Therapeutics is owned by institutions?
Institutions own about 0.3% of SLXN shares and 0.4% of the public float.
How much of Silexion Therapeutics do insiders own?
Insiders, such as officers and directors, own about 14.67% of SLXN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.